+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

North American Healthcare CDMO Market 2020-2026

  • PDF Icon

    Report

  • March 2021
  • Region: North America
  • Orion Market Research Private Limited
  • ID: 5331914
UP TO OFF until Dec 31st 2022
North American Healthcare Contract Development and Manufacturing Organization (CDMO) Market Size, Share & Trends Analysis Report by Services (Contract Development and Contract Manufacturing) and Forecast 2020-2026.

The North American healthcare CDMO market is estimated to grow significantly during the forecast period. The growing adoption of contract manufacturing and contract development services by the pharmaceutical and medical device companies is considered a major factor that propels the market growth in the region. The pharmaceutical contract manufacturing market in North America is being driven by the increased outsourcing of large pharmaceuticals companies to improve profit margins. Further, the large pharmaceutical companies in North America are also developing their contract research organization to develop a network in foreign countries. There are a large number of CDMO working in association with large pharmaceutical companies. These contract manufacturers have involved formulation, clinical trial manufacturing, and API development primarily. There is a surging demand for innovative drugs and medical devices across the region which has augmented the market growth of the North American Healthcare CDMO market in recent years.

The North American market for healthcare CDMO is segregated on the basis of services and region. Based on services, the market is further classified into contract development and contract manufacturing. The contract manufacturing services segment is projected to have a significant share in the North American healthcare CDMO market owing to the significant adoption of outsourcing services by pharmaceutical companies across the globe. Based on geography, the North American healthcare CDMO market is further segregated into the US and Canada. The US is projected to have a considerable share in the North American healthcare CDMO market owing to the presence of major market players and significant investment in drug discovery and development in the country.

The companies which are contributing to the growth of the North American healthcare CDMO market include AbbVie Inc., Baxter International, Inc., Catalent, Inc., Pfizer Inc., Thermo Fisher Scientific Inc., Jabil Inc., and others. Product launch, merger, and acquisition, collaborations with government, and technological advancements through which market players are considerably contributing to the market growth to stay competitive in the market.

Research Methodology

The market study of the North American healthcare CDMO market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. The research analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for pharmaceutical and medical device companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, products offered by the companies, and future market opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation

1. North American Healthcare CDMO Market Research and Analysis by Services

The Report Covers
  • Comprehensive research methodology of the North American healthcare CDMO market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the North American healthcare CDMO market.
  • Insights about market determinants that are stimulating the North American healthcare CDMO market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Market Determinants
3.1. Motivators
3.2. Restraints
3.3. Opportunities
4. Market Segmentation
4.1. North American Healthcare CDMO Market by Services
4.1.1. Contract Development
4.1.1.1. Clinical
4.1.1.2. Preclinical
4.1.1.3. Laboratory Services
4.1.2. Contract Manufacturing
4.1.2.1. Active Pharmaceutical Ingredients( API)
4.1.2.2. Finish Dosage Formulations
4.1.2.3. Medical Devices
5. Regional Analysis
5.1. United States
5.2. Canada
6. Company Profiles
6.1. AbbVie Inc.
6.2. Baxter International, Inc.
6.3. Catalent Inc.
6.4. Covance Inc.
6.5. Cambrex Corp.
6.6. Hisun Pharmaceuticals Inc.
6.7. Jabil Inc.
6.8. Pfizer Inc.
6.9. Stason Pharmaceuticals, Inc.
6.10. Thermo Fisher Scientific Inc.
List of Tables
1. North American Healthcare Cdmo Market Research and Analysis by Services, 2019-2026 ($ Million)
2. North American Contract Development Market Research and Analysis by Country, 2019-2026 ($ Million)
3. North American Contract Manufacturing Market Research and Analysis by Country, 2019-2026 ($ Million)

Companies Mentioned

A selection of companies mentioned in this report includes:

  • AbbVie Inc.
  • Baxter International, Inc.
  • Catalent Inc.
  • Covance Inc.
  • Cambrex Corp.
  • Hisun Pharmaceuticals Inc.
  • Jabil Inc.
  • Pfizer Inc.
  • Stason Pharmaceuticals, Inc.
  • . Thermo Fisher Scientific Inc.